Table 3.
Phenotype | SDHB | SDHC | SDHD | References |
---|---|---|---|---|
Multiple primary tumors | Not commom | Not common | Common | Raygada et al. (1); Pasini and Stratakis (25) |
Single primary tumors | Common | Common | Not common | Raygada et al. (1); Pasini and Stratakis (25) |
Extra adrenal tumors | Common (50%–67%) | Less common | Less common (18%–21%) | |
HNPGL | Less common (27%–31%) | Common | Common (71%–89%) | Niemann et al. (8) |
Risk for malignancy | High (34%–37%) | Low | Low (8%) | Bardella et al. (32); Benn et al. (33); |
Note: Many studies are still analyzing data and associated risks may change as more cases are reported.